About Us

J.A.R. Pharmaceuticals Ltd. was established in 1987 by Dr. James A. Rogers, PhD, with a mission to revolutionize the delivery of medications. Driven by a desire to bypass the gastrointestinal side effects often associated with oral medications for arthritis, Dr. Rogers, leveraging his extensive research in pharmaceutical sciences pharmacology, pioneered a topical solution that delivered active ingredients directly through the skin using advanced liposome technology.

​

This groundbreaking work led to the creation of PHLOJEL®, a premier topical product designed to offer targeted medication delivery in a safe and effective manner. 

Building on this success and committed to continual innovation, J.A.R. Pharmaceuticals further expanded its product line with the introduction of PHLOJEL® Ultra. This next-generation transdermal delivery system was developed to provide even more efficient drug absorption and enhanced patient comfort.

​

Following years of dedicated research and development, Dr. Rogers introduced PHLODERM™, a sophisticated skin moisturizer that combines the deep penetration abilities of PHLOJEL® Ultra with vital hydrating components. This product is uniquely formulated to not only moisturize but also to restore the skin’s natural barrier, offering relief and protection for even the most severe dry skin conditions.

​

Our journey from concept to leading pharmaceutical innovation underscores our commitment to improving patient care through science. Each product in our lineup reflects our ongoing dedication to quality, efficacy, and safety, providing trusted solutions for patients and healthcare providers alike.